Alamar Biosciences announced the passing of board member Ian Ratcliffe and subsequent board changes.

Key Highlights:

  • Ian Ratcliffe, independent director since Feb 2024, passed away on July 5, 2026; company extends condolences.
  • Board reduced the number of authorized directors constituting the full Board to five following his passing.
  • Nicholas Naclerio, Ph.D., was appointed to the Audit Committee of the Board.

Original SEC Filing:

This is an AI-powered summary. It may contain inaccuracies. Consider verifying important information with the source. Please note this summary is solely based on documents filed with the SEC.